Evidence of White Matter Neuroinflammation in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: A Diffusion-Based

Qiang Yu1, Kiana Kothe1, Richard A Kwiatek1

  • 1Thompson Institute, University of the Sunshine Coast, Birtinya, Queensland, Australia.

Human Brain Mapping
|March 16, 2026
PubMed

Insights

Neuroinflammation imaging reveals white matter changes in myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS). These changes, including cerebral edema and cellular infiltration, correlate with clinical symptoms, suggesting potential biomarkers for ME/CFS neuroinflammation.

Area of Science:

  • Neuroimaging
  • Neurology
  • Biomarkers

Background:

  • Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) is a complex disorder with suspected neuroinflammatory origins.
  • Previous diffusion tensor imaging (DTI) studies have yielded inconsistent findings regarding white matter abnormalities in ME/CFS.
  • Specific inflammatory changes within the white matter of ME/CFS patients remain poorly understood.

Purpose of the Study:

  • To investigate white matter neuroinflammation in ME/CFS using an advanced diffusion-based neuroinflammation imaging (NII) model.
  • To compare NII-derived metrics between ME/CFS patients and healthy controls (HCs).
  • To examine the relationship between NII metrics and clinical indicators of health and disability in ME/CFS.

Main Methods:

  • Diffusion MRI data were acquired from 67 ME/CFS patients and 67 matched HCs.
  • Seven NII-derived metrics (NII-HR, NII-RF, NII-FF, NII-AD, NII-RD, NII-MD, NII-FA) and conventional DTI metrics were computed.
  • Voxel-wise group comparisons using tract-based spatial statistics and multiple regression analyses were performed.

Main Results:

  • ME/CFS patients showed widespread white matter abnormalities compared to HCs, including lower NII-HR and NII-RF, and higher NII-FF, NII-AD, NII-MD, and NII-FA.
  • Specific regions exhibited decreased NII-AD and NII-MD in ME/CFS patients.
  • Lower NII-RF, NII-AD, and NII-MD were associated with poorer mental health, and lower NII-RF with higher disability.
  • Higher NII-FF correlated with lower disease severity in ME/CFS patients.
  • Conventional DTI revealed minimal group differences and no significant clinical associations.

Conclusions:

  • This study provides in vivo evidence of white matter neuroinflammation in ME/CFS.
  • NII metrics characterize neuroinflammation through cerebral edema (reduced NII-HR), cellular infiltration (reduced NII-RF), and axonal reorganisation (increased NII-FF).
  • NII-derived indices show promise as sensitive biomarkers for detecting neuroinflammation in ME/CFS.